Regeneron Pharmaceuticals Inc on Tuesday said its experimental twoantibody cocktail reduced viral levels and improved symptoms in nonhospitalized COVID19 patients, enhancing its chances of becoming a treatment for the disease that has killed over a million people worldwide.
United States Trade Representative (USTR) Katherine Tai had her first …
Pradhan Mantri Kisan Samman Nidhi: PM Kisan scheme beneficiaries can c…
Star Health IPO share allotment status has been finalised: Have you re…
Asian stocks came under pressure on Tuesday as a deadline for U.S. lawmake…
In the hours following the pandemonium at the Astroworld Festival that lef…
In the international market, Gold prices edged lower on Thursday, as the d…
from बिजनेस | दैनिक भास्कर https://ift.tt/3GAnG6F via ATGNEWS.COM…
from बिजनेस | दैनिक भास्कर https://ift.tt/3GBahLJ via ATGNEWS.COM…
Asian stocks came under pressure on Tuesday as a deadline for U.S. lawmake…
In the hours following the pandemonium at the Astroworld Festival that lef…
Post a Comment
0 Comments